Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 2Mesothelioma 2Lung Neoplasms 2Esophageal Neoplasms 2Thymus Neoplasms 1Sarcoma, Ewing 1Neoplasms, Germ Cell and Embryonal 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Cyclophosphamide 3Zoledronic Acid 2Vincristine 2Tranexamic Acid 2Temozolomide 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ibandronic Acid 2Etoposide 2Doxorubicin 2samarium Sm-153 lexidronam 1robatumumab 1pegfilgrastim 1eltrombopag 1delta 24-sterol reductase 1Sodium Pertechnetate Tc 99m 1Sodium Chloride 1Samarium 1Radiation 1Pregabalin 1Plicamycin 1Neutrons 1Ifosfamide 1Histocompatibility Testing 1Guanabenz 1Gemcitabine 1Fluoridation 1Fibrin Tissue Adhesive 1Etanercept 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Bone Neoplasms × Plicamycin × Clear all
NCT01610570 2018-03-02

Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
8 enrolled 20 charts
Sarcoma

Bone Neoplasms, Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡